MARKET WIREReuters • 2h ago
Oil slips more than 1% as talks continue on ending Iran war - ReutersOil slips more than 1% as talks continue on ending Iran war Reuters
Why ESYN Stock surged +3.10% Today — RQD Quant Desk Flash
$1.83 +3.10% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $1.84
EnerSyn Global Inc. (ESYN) carries a Roarable Rating of D- (Sell) with 41/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $54.4M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on ESYN Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is ESYN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-01, EnerSyn Global Inc. (NASDAQ: ESYN) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 41/100 at a spot price of $1.83 (+3.10% 1D, market cap $54.4M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, ESYN ranks #617 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does ESYN compare to ZSTK and COSM in the Health Care sector?
▼
Within the Health Care sector (Other Pharmaceuticals), ESYN carries a Roarable D- (41/100 RQD), trailing P/E of N/A, gross margin of 53.0%, and ROIC of -35.0%. By comparison, ZSTK (ZeroStack Corp.) holds a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M) and COSM (Cosmos Health Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $27.9M). Among the 5-stock peer group, ESYN leads on earnings multiple (N/A) while NUS leads on capital efficiency (6.7% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for ESYN?
▼
Per ESYN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001897245), EnerSyn Global Inc. generated $866.9K in revenue (-30.8% YoY), -$2.6M in net income, and -$1.8M in free cash flow against $4.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $1.84 (+0.37%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (41/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-7.7% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ESYN)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (41/100 Composite)
🔍 WHY ESYN SCORES 41/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+11/20 pts (27% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (27% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$2.16-10.2% Next Q
49
Q2 (-2Q)Grade D$1.94-12.4% Next Q
46
Q3 (-1Q)Grade D$1.70+7.6% Next Q
44
CurrentGrade D-$1.83-7.2% Hist 90D α
41
Trajectory: D (49) → D- (41)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a ESYN Turnaround Squeeze
While ESYN currently carries a cautious 41/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.03) and Max Pain ($1.92) forces dealer call-delta covering toward $2.95.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $ESYN• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ESYN Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ESYN Stock surged +3.10% Today — RQD Quant Desk Flash
EnerSyn Global Inc. (ESYN) surged +3.10% to $1.83, trading at 49% of its 52-week range ($0.88 – $2.81). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 49% of its 52-week range ($0.88 – $2.81) with RSI-14 at 42.6 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.83 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 46% gross margin and $0 annual free cash flow.
Live ESYN Headlines & Catalysts
MARKET WIREReuters • 3h ago
Nine people dead in Learjet crash in south Florida, officials say - ReutersNine people dead in Learjet crash in south Florida, officials say Reuters
MARKET WIREReuters • 5h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
MARKET WIRECNBC • 7h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 7h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 8h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 9h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 10h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ESYN)
- ✓Walkthrough of ESYN's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ESYN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +72.64%🛡️ HOLDING TREND SUPPORT
2026-10-30O $1.75H $1.83L $1.75C $1.83VOL 300
RES: $2.87SUP: $1.67SMA50: $2.03SMA200: $1.52
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ESYN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -30.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ESYN today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ESYN. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ESYN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ESYN)
Health Care Rank #617 of 1016
⚔️ ZSTK vs ESYN Full Matrix →
1. Head-to-Head Health Care Peer Comparison (ESYN vs. ZSTK, COSM, NUS, MEDS)
Industry: Other Pharmaceuticals (10 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, EnerSyn Global Inc. (ESYN) ranks #617 by composite RQD confidence (41/100, grade D-) and #737 by equity capitalization ($54.4M). Within this direct 5-issuer industry benchmark cohort, ESYN leads on earnings valuation at N/A trailing P/E, while NUS leads on capital efficiency and profitability with 6.7% ROIC and 69.4% gross margin. NUS currently holds the highest overall quantitative score in the immediate peer group at 62/100 (C) compared with ESYN at 41/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ESYN
ACTIVE
EnerSyn Global Inc. | D- | 41/100 | — | 53.0% | -35.0% | +3.10% | $54.4M | Benchmark Subject |
| ZSTK ZeroStack Corp. | E | 31/100 | — | 4.6% | -35.0% | -0.34% | $63.9M | /zstk-vs-esyn → |
| COSM Cosmos Health Inc. | E | 31/100 | — | 12.1% | -35.0% | +11.45% | $27.9M | /cosm-vs-esyn → |
| NUS Nu Skin Enterprises Inc. | C | 62/100 | — | 69.4% | 6.7% | -1.47% | $228.3M | /nus-vs-esyn → |
| MEDS DataMeds AI Inc. | E | 30/100 | — | -27.5% | -35.0% | -7.73% | $9.8M | /meds-vs-esyn → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001897245In its most recent audited fiscal period (FY2025, filed 2025-12-31), EnerSyn Global Inc. (ESYN) reported GAAP revenue of $866.9K (-30.8% vs. FY2024 revenue of $1.3M , and +73120.1% cumulative change since FY2023) , GAAP net income of -$2.6M, operating cash flow of -$1.8M, and free cash flow of -$1.8M (+4.3% YoY). On the balance sheet, ESYN closed FY2025 with $4.6M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $866.9K | -$2.6M | -$1.8M | -$1.8M | $4.6M | — |
| FY2024 (FY) | 2024-12-31 | $1.3M | -$2.7M | -$1.8M | -$1.8M | $6.4M | — |
| FY2023 (FY) | 2023-12-31 | $1.2K | -$1.1M | -$2.6M | -$2.6M | — | — |
3. ESYN Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ESYN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, EnerSyn Global Inc. (NASDAQ: ESYN) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 41/100 at a spot price of $1.83 (+3.10% 1D, market cap $54.4M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, ESYN ranks #617 in composite RQD confidence.
How does ESYN compare to ZSTK and COSM in the Health Care sector?
Within the Health Care sector (Other Pharmaceuticals), ESYN carries a Roarable D- (41/100 RQD), trailing P/E of N/A, gross margin of 53.0%, and ROIC of -35.0%. By comparison, ZSTK (ZeroStack Corp.) holds a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M) and COSM (Cosmos Health Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $27.9M). Among the 5-stock peer group, ESYN leads on earnings multiple (N/A) while NUS leads on capital efficiency (6.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ESYN?
Per ESYN's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001897245), EnerSyn Global Inc. generated $866.9K in revenue (-30.8% YoY), -$2.6M in net income, and -$1.8M in free cash flow against $4.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ESYN trading relative to its 50-day, 200-day, and 52-week technical levels?
ESYN last traded at $1.83 (+3.10% on volume of 3,886 shares), positioning the stock -9.85% below its 50-day simple moving average ($2.03) and +20.39% above its 200-day simple moving average ($1.52). Across its 52-week range of $0.88 to $2.81, ESYN sits at the 49.2% percentile with a 14-day RSI of 42.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.60 to $2.06).
ESYN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ESYN stock moving today?
Why ESYN Stock surged +3.10% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.